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Microalbuminuria (MA) is a cardiovascular risk factor. The aim
of this study was to examine the relationship between MA
and the intima–media complex of the carotid and brachial
artery, endothelial function, glucose metabolism,
haemostatic variables and cardiac hypertrophy in patients
with coronary heart disease. A total of 123 patients, aged
31–80 years, with a history of previous myocardial infarction
and without known diabetes mellitus were examined with
B-mode ultrasound of common carotid and brachial arteries,
flow-mediated dilatation of the brachial artery and
echocardiography. A standard oral glucose tolerance test
with 75 g of glucose was performed. MA was defined as
excretion of 20–200 lg albumin/min. MA was present in 11%
of patients. Patients with MA had significantly higher level of
2-h plasma glucose, a lower displacement of the
atrioventricular plane, a thicker septum wall and a higher
prevalence of impaired glucose tolerance test compared with
patients with normoalbuminuria (Po0.05). Urinary albumin
excretion (UAE) was significantly and positively associated
with calculated intima–media area (cIMa) in both brachial and
common carotid arteries as well as with age and
interventricular septum thickness. In conclusion, UAE was
significantly and positively associated with cIMa in both the
common carotid and the brachial arteries as well as with left
ventricular septum thickness and glucose intolerance in
patients with a history of previous myocardial infarction
without known diabetes mellitus.
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Microalbuminuria (MA), that is, slightly elevated urinary
albumin excretion (UAE), is an established marker for both
end-stage renal disease and cardiovascular morbidity and
mortality in patients with diabetes mellitus.1,2 Previous
studies have shown that increased UAE constitutes an
independent predictor of cardiovascular morbidity also in
non-diabetic subjects,3 in the elderly,4 in the general
population,5 as well as in hypertensive patients.6
Several studies have shown an increased intima–media
thickness (IMT) of the carotid artery in patients with MA.7,8
Although a vast majority of previous IMT studies have
examined the carotid artery, a few study groups have recently
reported IMT measurements from the brachial artery.9–11
According to several cross-sectional studies, UAE also
correlates with left ventricular hypertrophy6,12 in hyperten-
sive patients. Left ventricular hypertrophy is considered as a
potent risk marker for cardiovascular events through its
negative effects on ventricular function, coronary circulation
and arrhythmogenesis. Although the association between
UAE and left ventricular hypertrophy in most studies was
explained by blood pressure,13 there are studies showing that
this association is independent of blood pressure levels.14
Furthermore, some studies have demonstrated a significant
relationship between MA and different haemostatic variables
such as plasminogen activator inhibitor-1 activity,7 von
Willebrand factor and fibrinogen.15
Previous studies of MA have mainly been focused on
patients with diabetes mellitus. Therefore, the aim of this
study was to examine the relationship between MA and the
intima–media complex of the carotid and brachial artery,
endothelial function, glucose metabolism, haemostatic vari-
ables and cardiac hypertrophy in patients with coronary heart
disease.
RESULTS
Clinical demographic data are given in Table 1. MA was
present in 11% of patients. Patients with MA had
significantly higher levels of 2-h plasma glucose compared
with patients with normoalbuminuria (Table 1). A total of
53% of patients with MA had impaired glucose tolerance
(IGT) and one patient had diabetes mellitus; 11% of patients
with normoalbuminuria had diabetes mellitus and 22% had
IGT (Po0.05); 122 (99%) patients were taking aspirin and
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111 (90%) b-blockers. Statins were given to 111 (90%)
patients and 31 (25%) received angiotensin-converting
enzyme inhibitors.
Table 2 shows ultrasound characteristics of the patients,
including flow-mediated dilatation (FMD), calculated intima–
media complex area and echocardiographic measurement of
the left ventricle. Septum thickness was significantly thicker in
microalbuminuric patients compared to normoalbuminuric
patients (Po0.05). The displacement of the atrioventricular
(AV) plane of the left ventricle was significantly smaller in
patients with MA compared with patients with normoalbu-
minuria (Po0.05).
The univariate Spearman correlation coefficients between
study variables and UAE are given in Table 3. UAE was
significantly and positively associated with calculated in-
tima–media area (cIMa) in both the brachial and common
carotid arteries, age and interventricular septum thickness.
No other significant relationships were found. When log
transformation of UAE was used as a dependent variable and
cIMa in the brachial artery, cIMa in common carotid arteries,
age and interventricular septum thickness were used as
independent variables in the multiple stepwise regression
analysis, a significant and independent relationship was
observed between UAE and septum thickness of the left
chamber (Po0.05).
DISCUSSION
There are only a few studies of microalbuminuric patients
with already established clinical atherosclerosis. Our study is
unique in that aspect, as MA in patients with previous
myocardial infarction was evaluated. The main finding of this
study was that in patients with a history of previous
myocardial infarction, UAE was significantly and positively
associated with cIMa in both the common carotid and the
brachial arteries as well as with left ventricular septum
thickness and glucose intolerance.
Most previous studies regarding MA have been performed
in patients with diabetes mellitus or hypertension. Our
findings are in concordance with previous studies reporting a
significant relationship between MA and left ventricular
hypertrophy.7,12 We also confirm the previously reported
association between increased IMT of the carotid artery and
an unfavourable left ventricular geometry.16,17 However, this
is the first study, to our knowledge, showing that UAE is
associated with cIMa of both common carotid and brachial
arteries as well as with left ventricular septum thickness. The
blood pressure level did not explain this relationship as there
was no significant difference in blood pressure in patients
with MA compared with those without MA and UAE was not
significantly associated with the blood pressure level. A total
of 25% of enrolled patients were treated with angiotensin-
converting enzyme inhibitors and 90% with b-blockers. It is
therefore highly reasonable to assume that the lack of
association between blood pressure and UAE in the present
study, in contrast to several previous reports, may be
Table 1 | Characteristics of subjects with and without micro-
albuminuria
Variable
Microalbuminuria
(n=13)
Normoalbuminuria
(n=110)
Age (years) 64711 61711
BMI (kg/m2) 26.773.9 26.573.5
Systolic blood pressure (mmHg) 144722 137720
Diastolic blood pressure (mmHg) 82710 7979
Heart rate (bpm) 59713 58710
Fasting plasma glucose (mmol/l) 6.272.5 5.371.1
2-h plasma glucose (mmol/l) 974.0* 7.572.9
Total cholesterol (mmol/l) 4.771 4.770.9
Triglycerides (mmol/l) 1.870.9 1.671
von Willebrand factor (IU/ml) 1.570.6 1.370.4
Plasminogen activator inhibitor 1
activity (IU/ml)
33.5733.4 17.8716.4
Fibrinogen (g/l) 3.571 3.370.7
Prothrombin (nmol/l) 0.870.3 0.970.8
Hs-CRP (mg/l) 2.572.3 3.575.5
Prevalence of DM (n (%)) 1 (8) 12 (11)
Prevalence IGT (n (%)) 7 (53)** 25 (22)
Prevalence NPG (n (%)) 5 (38) 73 (66)
*Po0.05, Mann–Whitney test; **Po 0.05, w2 test.
BMI, body mass index; DM, diabetes mellitus; IGT, impaired glucose tolerance test;
hs-CRP, high-sensitivity C-reactive protein; NPG, normal plasma glucose.
Table 2 | Ultrasound data of the subjects with and without
microalbuminuria
Variable
Microalbuminuria
(n=13)
Normoalbuminuria
(n=110)
Carotid examination
Calculated common carotid
intima–media area (mm2)
(mean of right and left side)
19.276.5 17.674.9
Brachial examination
Calculated brachial artery
intima–media area (mm2)
5.171.3 5.171.6
Flow-mediated dilation (%) 2.872.6 2.271.9
Cardiac examination
Left chamber diameter (mm) 4775 4976
Septum thickness (mm) 11.571.4* 10.971.5
AV-mean (mm) 1072* 1274
Ejection fraction (%) 5279 5679
AV-mean, atrioventricular plane displacement.
*Po0.05.
Table 3 | Correlation between UAE and study variables
UAE (mg/l)
Calculated brachial artery intima–media area (mm2) 0.24*
Calculated common carotid intima–media area (mm2)
(mean of right and left side)
0.19*
Age 0.23*
Septum thickness (mm) 0.22*
Spearman correlation coefficients are given. UAE, urinary albumin excretion.
*Po0.05.
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influenced by the post-infarction medication. Inhibition of
the renin–angiotensin system with angiotensin-converting
enzyme inhibitor is particularly effective at reducing UAE
rates. Several, but not all,18 previous studies have reported an
association between IMT of the carotid artery and UAE.7,8
The different outcome regarding this relationship might be
explained by different patient populations. MA is more
common among subjects with diabetes mellitus and it is
possible that the pathophysiological background of MA in
patients with coronary heart disease may differ from diabetic
subjects. Elevated hydrostatic pressure in the microcircula-
tion, which strongly depends on the blood pressure level, may
at least partly explain the elevated prevalence of MA in
hypertensive subjects. Nosadini et al.19 recently suggested that
MA in type II diabetes with hypertension may be due to
abnormalities of slit diaphragm and podocyte protein
expression, irrespective of the overall leakage of albumin
from the circulation, indicating another mechanism of MA
than through the blood pressure level. According to the Steno
hypothesis,20 albuminuria in diabetic subjects reflects vas-
cular damage secondary to abnormality of the glomerular
basement membrane.
Thus, this study demonstrates that MA is associated with
both cardiac and extra-cardiac vascular damage. This is a
cross-sectional study and we cannot explain the pathophy-
siological explanation behind this relationship. However, we
can state that MA seems to be a marker for hypertrophy in
both the left heart chamber and peripheral vessels in this
patient group. Therefore, it appears to be relevant to measure
UAE in this patient group. This was also concluded by Berton
et al.,21 who demonstrated a marked increased in UAE in the
acute phase of myocardial infarction. After the initial rise,
urinary albumin progressively fell towards normal level
during the week after admission to hospital, and UAE was
found to be a better predictor of in-hospital mortality than
echocardiographic left ventricular ejection fraction.
In agreement with a previous study,22 we found no
association between FMD and MA. FMD seems not to be a
reliable surrogate for the detection of established coronary
atherosclerosis. It may be more suitable as a tool for the
detection of risk factor exposure in the earliest functional
stage of arteriosclerosis, whereas morphologic measurements,
such as IMT, are more closely related to the end stage of
atherosclerotic process.
Data from our study showed that 11% of the study
patients have MA 1–12 months after acute myocardial
infarction (AMI). The vast majority of the patients in this
study were examined 3–4 months after the myocardial
infarction. Therefore, one can presume that the UAE values
were measured during steady-state conditions. Previous
studies have reported that the prevalence of MA is around
6% in the general population,3 whereas much higher
prevalence values are observed in subjects with diabetes
mellitus and hypertension.1–4 There are sparse data regarding
the prevalence of MA in non-diabetic subjects with a
previous myocardial infarction.
According to Gosling et al.,23 MA is the consequence of
the inflammatory reaction that accompanies AMI and
involves renal vascular system. An increase in high-sensitivity
C-reactive protein and serum amyloid A has previously been
reported in patients with unstable angina and AMI.24 The
lack of association between UAE and high-sensitivity C-
reactive protein in our study may be explained by the fact
that the patients were included at least 1 month after the
myocardial infarction, when inflammatory markers had
fallen towards normal range. Furthermore, almost all study
patients were treated with statins, which may have an inverse
effect on the level of CRP.
Despite the fact that none of the patients had a known
diabetes mellitus, the prevalence of IGT was higher among
microalbuminuric patients compared to normoalbuminuric
subjects (54 vs 22%), and plasma glucose 120 min after
glucose ingestion during the oral glucose tolerance test was
also higher in the microalbuminuric group. This observation
suggests that IGT is associated with renal dysfunction, which
may precede the onset of diabetes. A 3.5-year follow-up study
by Mykkanen et al.25 showed that subjects with MA and IGT
were more likely to become diabetic compared with patients
with normoalbuminuria. The relation between IGT and MA
is in accordance with several previous studies.15,26,27
In this study, we have found that the motion of the AV
plane at the left ventricular walls was smaller and the septum
thicker in patients with MA compared with patients with
normoalbuminuria. The motion of the AV plane declines
with increasing age,28 but there was no difference in age
between the groups. Decreased AV plane motion may be an
early preclinical sign of disturbed left ventricular function in
patients with MA; however, this relationship has to be
interpreted cautiously and needs future validation.
In contrast to several other studies,7,15 no association
between UAE and the measured metabolic haemostatic
variables was observed. The reason for this discordance is
unknown, but may be due to selection of different study
groups.
There are limitations to this study. The study group is
rather small and also special; therefore the results cannot be
generalized to other patient groups.
In conclusion, the main finding of this study was that in
patients with a history of previous myocardial infarction
without known diabetes mellitus, UAE was significantly and
positively associated with cIMa in both the common carotid
and the brachial arteries as well as with left ventricular
septum thickness and glucose intolerance.
MATERIALS AND METHODS
Subjects
A total of 123 patients, men (75%) and women (25%) aged 31–80
years, with a history of previous AMI were included. The inclusion
criterion was hospital-diagnosed myocardial infarction occurring
1–12 months before the examinations. The patients were recruited
from the Department of Cardiology at Karolinska University
Hospital, Huddinge, Sweden. A majority of the patients were
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recruited at the post coronary care unit, 2–3 days after the
myocardial infarction. The examinations of this study were
performed 1–12 months after the index event. The exclusion
criterion was known diabetes mellitus. All subjects gave informed
consent after written and oral information. The ethics committee of
the Karolinska Institute at Karolinska University Hospital, Huddinge
approved the study.
AMI was defined using the criteria of the European Society of
Cardiology29 and the American College of Cardiology.30 Thus,
patients were diagnosed as having an AMI if they had two values
of serum troponin T greater than 0.05 g/l together with either
typical symptoms or new Q-waves in at least two of the 12 standard
electrocardiographic leads, or electrocardiogram changes indi-
cating acute ischaemia (ST-elevation, ST-depression or T-wave
inversion).
Measurements
Venous blood was drawn after an overnight fast and 5 min of supine
rest for determination of serum levels of cholesterol and triglycerides
using established methods. An immunophelometric assay, N High
Sensitivity CRP (DadeBehring, Miami, FL), was used to estimate
CRP levels.31 Venous blood was also drawn with minimal cuff pre-
ssure for analysing the haemostatic markers, including fibrinogen,
von Willebrand factor, tPA antigen, plasminogen activator inhibitor-
1 and prothrombin fragment 1þ 2. The citrated blood samples were
centrifuged within 30 min, and plasma was immediately frozen in
aliquots and stored at 701C until analysis. plasminogen activator
inhibitor-1 activity was determined using the Spectrolyze PAI-1 kit
(Biopool AB, Umea˚, Sweden) on the citrated plasma samples that
had been stored at 701C. Determination of tPA antigen was per-
formed on stored citrated plasma samples using the kit from Biopool
TintElize tPA (from Biopool AB, Umea˚, Sweden). Von Willebrand
factor antigen was measured by a commercially available enzyme-
linked immunosorbent assay method (Liatests vWF kit, Stago, pro-
vided by Triolab AB). Fibrinogen levels in plasma were determined by
conventional techniques (Sysmex CA-1500, Holliston, MA). The level
of prothrombin fragment Iþ II was assessed using enzyme-linked
immunosorbent assay kits (Enzygnost F1þ 2, Behring, Germany).
A standardised oral glucose tolerance test with 75 g of glucose
(dissolved in 250 ml water) was performed after an overnight fast.
Plasma glucose concentrations at 0, 30, 60, 90 and 120 min following
ingestion of 75 g glucose were analysed, using the glucose oxidase
technique on a Hitachi 917 system (Ibari-ken, Japan). Diabetes
mellitus and IGT were defined according to the criteria given in the
1998 Report of a World Health Organization Consultation.32 On the
basis of 2-h plasma glucose alone, individuals were classified into
categories of newly diagnosed diabetes, IGT and normal glucose
tolerance if their 2-h plasma glucose concentrations were X11.1,
7.8–11.0 and o7.8 mmol/l, respectively. On the basis of fasting
plasma glucose alone, individuals were classified into categories of
newly diagnosed diabetes, impaired fasting glucose and normal
fasting glucose, using cut levels of X7.0, 6.1–6.9 and o6.1 mmol/l,
respectively. The patients were thus classified as having diabetes
mellitus if their fasting plasma glucose exceeded 7.0 mmol/l or their
2-h plasma glucose concentration exceeded 11.0 mmol/l, or both.
Resting blood pressure was measured in the right arm after about
10 min supine rest. Patients were asked to bring two overnight
(12-h) urine samples for determination of UAE using an
immunochemistry nephelometry method. The mean of two
measurements was used in the statistical analysis. MA was defined
as excretion of 20–200 mg albumin/min. Body mass index was
measured according to recommended principles. Smoking status
was assessed by a questionnaire.
Carotid B-mode ultrasonography
The right and left carotid arteries were examined with a duplex
scanner (Aspen, Acuson, Mountain View, CA) using a 7 MHz linear
array transducer. The same trained sonographer performed all
scannings. The far wall of the common carotid artery, 0.5–1.0 cm
proximal to the beginning of the carotid bulb, was used for
measurements of the IMT and lumen diameter. The examinations
were video taped for subsequent analyses by a computer system33
with automated tracing of echo interfaces and measurements of
distances between the wall echoes within a 10-mm-long section of
common carotid artery in late diastole, defined by a simultaneous
electrocardiographic recording. The mean values of the IMT and
lumen diameter within the 10-mm-long section were calculated. The
differences between repeated measurements of IMT and lumen
diameter, using the automated analysing system, were 3.2 and 0.6%
(coefficient of variation), respectively (with an IMT of 0.48–1.04 mm
and a lumen diameter of 4.34–7.91 mm). To compensate for the
stretching effect of arterial distension (secondary to increased
arterial pressure) on the wall thickness, the cross-sectional
intima–media area was calculated using the formula 3.14((lumen
diameter/2þ IMT)2(lumen diameter/2)2). This cIMa, but not the
IMT, has been shown by us to be unaffected by variations in artery
distension secondary to changes in blood pressure.34 The ultra-
sonographic methods used have been described in detail pre-
viously.35,36
Flow-mediated dilation and intima–media thickness of the
brachial artery
The ultrasound procedures for assessing endothelium-dependent
FMD were performed as described in the international guidelines by
Corretti et al.37 The patients were examined in the morning after
fasting since midnight. The patients were told not to use long-acting
nitroglycerin or calcium channel blocker drugs for 36 h before the
examination. A high-resolution ultrasound scanner (System Five,
GE Vingmed, Horten, Norway) with a 10.0 MHz linear array
transducer was used. After the 10-min equilibration period at rest in
the recumbent position, a single dedicated ultrasonographer
performed measurements of the left brachial artery FMD. Scans of
the brachial artery were taken proximal to the antecubital fossa and
saved on videotape. The transducer was fixed with a stand during
the FMD examinations. Baseline diameter recordings were obtained,
after which arterial occlusion was performed by inflating a forearm
blood pressure cuff (12.5 cm wide) to 250 mmHg for 4.5 min. After
cuff release, diameter recordings were repeated during the post-
occlusive increase in brachial artery blood flow. Arterial flow
velocity recordings were obtained using pulsed wave Doppler at 601
to the vessel with the sample volume (1.5 mm) in the centre of the
artery. The velocity time integral increased by 3197150% after cuff
deflation. The complete experimental sequence was performed twice
at a 30 min interval.
Images were digitally acquired from the videotape and measured
in random order by a single observer blinded to the conditions
under which the ultrasonic images were obtained. A computer
system33 with automated tracing of echo interfaces and measure-
ments of distances between the wall echoes within a 5-mm-long
section of the brachial artery was used. Brachial artery diameter was
calculated in diastolic frames taken coincidentally with the R wave
on the electrocardiogram twice at rest and then 45, 60 and 75 s after
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cuff deflation. A mean of the diameters after 45, 60 and 75 s was
calculated. Diameter changes were expressed as the percentage
change relative to the mean baseline value. The mean of two FMD
examinations was used. The cross-sectional cIMa of the brachial
artery was calculated using the same formula as for the common
carotid intima–media area. The differences between repeated
measurements of IMT, lumen diameter and FMD, using the
automated analysing system, were 3.0, 1.4 and 5.5% (coefficient of
variation), respectively.
Echocardiography
All patients underwent a standard echocardiographic evaluation,
using a 2.5 MHz transducer (System Five, GE Vingmed, Horten,
Norway). The echocardiographic studies were performed with the
subject in the left lateral decubitus position. One physician, unaware
of the other patient data, recorded all the echocardiograms. Left
ventricular internal dimension and interventricular septum thick-
ness and ejection fraction were measured according to the
recommendations of the American Society of Echocardiography.38
The motion of the AV plane was assessed from the four-chamber
apical view, using M-mode as described previously.39
Statistical analysis
Results are reported as mean7s.d., except where indicated
otherwise. All data analyses were made using Statistica for Windows
software version 6.0. Mann–Whitney U-test, w2 test, Spearman’s
correlation of coefficient and stepwise regression analysis were
performed. Since UAE was not normally distributed, a log
transformation was performed before the multivariate significance
test. Statistical significance was taken at the level of Po0.05.
ACKNOWLEDGMENTS
This study was supported by grants from Karolinska Institute and the
Swedish Swedish Heart–Lung Foundation. We thank RN Margareta
Berglund for excellent support with recruitment of patients, data
collection, analyses and presentation.
REFERENCES
1. Bennett PH, Haffner S, Kasiske BL et al. Screening and management of
microalbuminuria in patients with diabetes mellitus: recommendations to
the Scientific Advisory Board of the National Kidney Foundation from an
ad hoc committee of the Council on Diabetes Mellitus of the National
Kidney Foundation. Am J Kidney Dis 1995; 5: 107–112.
2. Deckert T, Yokoyama H, Mathiesen E et al. Cohort study of predictive
value of urinary albumin excretion for atherosclerotic vascular
disease in patients with insulin dependent diabetes. BMJ 1996; 312:
871–874.
3. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of
vascular disease in non-diabetic subjects. Islington Diabetes Survey.
Lancet 1998; 2: 530–533.
4. Nakamura S, Kawano Y, Inenaga T et al. Microalbuminuria and
cardiovascular events in elderly hypertensive patients without previous
cardiovascular complications. Hypertens Res 2003; 26: 603–608.
5. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B et al. Very low levels of
microalbuminuria are associated with increased risk of coronary heart
disease and death independently of renal function, hypertension, and
diabetes. Circulation 2004; 110: 32–35.
6. Pedrinelli R, Dell’Omo G, Di Bello V et al. Microalbuminuria, an integrated
marker of cardiovascular risk in essential hypertension. J Hum Hypertens
2002; 16: 79–89.
7. Agewall S, Bjorn F. Microalbuminuria and intima–media thickness of the
carotid artery in clinically healthy men. Atherosclerosis 2002; 164:
161–166.
8. Mykkanen L, Zaccaro DJ, O’Leary DH et al. Microalbuminuria and carotid
artery intima–media thickness in nondiabetic and NIDDM subjects. The
Insulin Resistance Atherosclerosis Study (IRAS). Stroke 1997; 28:
1710–1716.
9. Bucciarelli P, Sramek A, Reiber JH, Rosendaal FR. Arterial intima–media
thickness and its relationship with cardiovascular disease and
atherosclerosis: a possible contribution of medium-sized arteries.
Thromb Haemost 2002; 88: 961–966.
10. Frick M, Schwarzacher SP, Alber HF et al. Morphologic rather than
functional or mechanical sonographic parameters of the brachial artery
are related to angiographically evident coronary atherosclerosis. J Am Coll
Cardiol 2002; 40: 1825–1830.
11. Agewall S, Henareh L, Jogestrand T. Intima–media complex of the
brachial artery is associated with intima–media complex of the common
carotid artery and with left ventricular hypertrophy in patients with
coronary heart disease. J Hypertens 2004; 22: 1–7.
12. Tsioufis C, Stefanadis C, Toutouza M et al. Microalbuminuria is
associated with unfavourable cardiac geometric adaptations in essential
hypertensive subjects. J Hum Hypertens 2002; 16: 249–254.
13. Pontremoli R, Nicolella C, Viazzi F et al. Microalbuminuria is an early
marker of target organ damage in essential hypertension. Am J Hypertens
1998; 11: 430–438.
14. Nilsson T, Svensson A, Lapidus L et al. The relations of microalbuminuria
to ambulatory blood pressure and myocardial wall thickness in a
population. J Intern Med 1998; 244: 55–59.
15. Agewall S, Fagerberg B, Attvall S et al. Microalbuminuria, insulin
sensitivity and haemostatic factors in non-diabetic treated hypertensive
men. Risk Factor Intervention Study Group. J Intern Med 1995; 237:
195–203.
16. Muiesan ML, Salvetti M, Zulli R et al. Structural association between the
carotid artery and the left ventricle in a general population in Northern
Italy: the Vobarno study. J Hypertens 1998; 16: 1805–1812.
17. Roman MJ, Pickering TG, Schwartz JE et al. Relation of arterial structure
and function to left ventricular geometric patterns in hypertensive adults.
J Am Coll Cardiol 1996; 28: 751–756.
18. Epidemiology of Diabetes Interventions and Complications (EDIC)
Research Group. Effect of intensive diabetes treatment on carotid artery
wall thickness in the epidemiology of diabetes interventions and
complications. Diabetes 1999; 48: 383–390.
19. Nosadini R, Velussi M, Brocco E et al. Altered transcapillary escape of
albumin and microalbuminuria reflects two different pathogenetic
mechanisms. Diabetes 2005; 54: 228–233.
20. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K et al. Albuminuria reflects
widespread vascular damage: the Steno hypothesis. Diabetologia 1989;
32: 219–226.
21. Berton G, Citro T, Palmieri R et al. Albumin excretion rate increases during
acute myocardial infarction and strongly predicts early mortality.
Circulation 1997; 96: 3338–3345.
22. Balletshofer BM, Braun B, Rittig K et al. Urinary albumin excretion and
noninvasive assessment of peripheral endothelial dysfunction with
high-resolution ultrasound in type 2 diabetic subjects and nondiabetic
controls. Med Klin (Munich) 2003; 98: 253–258.
23. Gosling P, Hughes EA, Reynolds TM, Fox JP. Microalbuminuria is an early
response following acute myocardial infarction. Eur Heart J 1991; 12:
508–513.
24. Morrow DA, Rifai N, Antman EN et al. Serum amyloid A predicts early
mortality in acute coronary syndromes: a TIMI 11A substudy. J Am Coll
Cardiol 2000; 35: 358–362.
25. Mykkanen L, Haffner SM, Kuusisto J et al. Microalbuminuria precedes the
development of NIDDM. Diabetes 1994; 43: 552–557.
26. Takahashi N, Anan F, Nakagawa M et al. Microalbuminuria, cardiovascular
autonomic dysfunction, and insulin resistance in patients with type 2
diabetes mellitus. Metabolism 2004; 53: 1359–1364.
27. Agewall S, Persson B, Samuelsson O et al. Microalbuminuria in treated
hypertensive men at high risk of coronary disease. The Risk Factor
Intervention Study Group. J Hypertens 1993; 11: 461–469.
28. Edner M, Jarnert C, Muller-Brunotte R et al. Influence of age and
cardiovascular factors on regional pulsed wave Doppler myocardial
imaging indices. Eur J Echocardiogr 2000; 1: 87–95.
29. Van de Werf F, Ardissino D, Betriu A et al. Management of acute
myocardial infarction in patients presenting with ST-segment elevation.
The Task Force on the Management of Acute Myocardial Infarction of the
European Society of Cardiology. Eur Heart J 2003; 24: 28–66.
30. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction
redefined – a consensus document of The Joint European Society of
Cardiology/American College of Cardiology Committee for the
redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959–969.
31. Chenillot O, Henny J, Steinmetz J et al. High sensitivity C-reactive protein:
biological variations and reference limits. Clin Chem Lab Med 2000; 38:
1003–1011.
182 Kidney International (2006) 69, 178–183
o r i g i n a l a r t i c l e L Henareh et al.: Microalbuminuria and coronary heart disease
32. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes
mellitus and its complications. Part 1: diagnosis and classification of
diabetes mellitus provisional report of a WHO consultation. Diabet Med
1998; 15: 539–553.
33. Wendelhag I, Liang Q, Gustavsson T, Wikstrand J. A new automated
computerized analyzing system simplifies readings and reduces the
variability in ultrasound measurement of intima–media thickness. Stroke
1997; 28: 2195–2200.
34. Jogestrand T, Nowak J, Sylve´n C. Improvement of common carotid
intima–media complex measurements by calculating the cross-sectional
area. J Vasc Invest 1995; 4: 193–195.
35. Lemne C, Jogestrand T, de Faire U. Carotid intima–media thickness and
plaque in borderline hypertension. Stroke 1995; 26: 34–39.
36. Nowak J, Nilsson T, Sylven C, Jogestrand T. Potential of carotid
ultrasonography in the diagnosis of coronary artery disease: a
comparison with exercise test and variance ECG. Stroke 1998; 29:
439–446.
37. Corretti MC, Anderson TJ, Benjamin EJ et al. Guidelines for the
ultrasound assessment of endothelial-dependent flow-mediated
vasodilation of the brachial artery: a report of the International
Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39:
257–265.
38. Schiller NB, Shah PM, Crawford M et al. Recommendations for
quantitation of the left ventricle by two-dimensional echocardiography.
American Society of Echocardiography Committee on Standards,
Subcommittee on Quantitation of Two-Dimensional Echocardiograms.
J Am Soc Echocardiogr 1989; 2: 358–367.
39. Owen A. Effect of increasing age on diastolic motion of the left
ventricular atrioventricular plane in normal subjects. Int J Cardiol 1999;
69: 127–132.
Kidney International (2006) 69, 178–183 183
L Henareh et al.: Microalbuminuria and coronary heart disease o r i g i n a l a r t i c l e
